Stock overview
BridgeBio Pharma Inc.
Explore the company, reported ownership, price history, and available source evidence.
BridgeBio Pharma Inc. (BBIO) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $78.01
- · BBIO
- Tracked holders
- 5 funds
- Latest available 13F per fund
BBIO · USD
Price
Close · Nov 18, 2026
- Range low
- $5.21
- Range high
- $90.17
- Observations
- 1255
- Session date
- Nov 18, 2026
Nov 18, 2021–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Viking Global Investors largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | −2% 26'Q3 | $644,328,010 | 1.97% |
| Sequoia Capital position history Q3 2026 · filed Nov 13, 2026 · SEC filing | — | $122,411,951 | 0.48% |
| Renaissance Technologies position history Q3 2026 · filed Nov 12, 2026 · SEC filing | −0% 26'Q3 | $56,360,727 | 0.08% |
| Gotham Asset Management position history Q3 2026 · filed Nov 16, 2026 · SEC filing | Newly reported 26'Q3 | $457,244 | 0% |
| Polen Capital Management position history Q3 2026 · filed Nov 13, 2026 · SEC filing | +13% 26'Q3 | $296,758 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market